 Statistical considerations cancer screening programs goal cancer screening early detection treatment disease consequent reduction mortality rate Evaluation particular screening program goal difficult task components screening process first ability test cancer number false-positive results regard specificity test high test prostate cancer specificity high prostate cancer program available tests problem large number false-positive findings overall impact screening program procedure randomized trial cancer-specific mortality endpoint endpoint lead time length biases outcome variables stage shift case survival controlled trial costly usual therapy trial differences study populations trial design relative population intervention extent knowledge disease natural history important component evaluation decision screening program cost-effectiveness analysis decision ranking cost-to-benefit ratios various programs limited funds cost cost test cost side effects test costs biopsy treatment benefit terms lives life years quality-adjusted life years